RIM
VRTX icon

Reliant Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Reliant Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,922
Closed -$3.21M – 63
2021
Q2 		$3.21M Buy
+15,922
New +$3.33M 1.48% 39

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reliant Investment Management's VRTX Position: Q3 2021 in Review

Reliant Investment Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 15,922 shares — an estimated $3.21M sold.

Reliant Investment Management first reported a position in VRTX in Q2 2021 and held it in 1 quarter. The position peaked at $3.21M in Q2 2021. 934 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

  • Reliant Investment Management reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Reliant Investment Management sold 15,922 Vertex Pharmaceuticals shares in Q3 2021, an estimated $3.21M.
  • Reliant Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • Reliant Investment Management's Vertex Pharmaceuticals position peaked at $3.21M in Q2 2021.
  • 934 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Reliant Investment Management's 13F filing for Q3 2021, filed 14 Oct 2021.